In comparison to the control group, a 4.8-fold (p < 0.001) and a 3.4-fold (p < 0.001) elevation in the mRNA expression of SREBP-1c and ChREBP transcripts, respectively, as well as a 5.7-fold (p < 0.001) increase in the FASN gene expression was detected in the liver of WD group mice. Here, MLXIPL is linked to Wilson disease.